Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
---|
02/25/2009 | EP1506188B1 Process for the preparation of a hydrate of an anthranilic acid derivative |
02/25/2009 | CN100463909C Synthesis method of thienotetrahydropyridine acetonitrile |
02/24/2009 | US7495026 Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents |
02/24/2009 | US7494721 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
02/19/2009 | WO2009022738A1 Coloring composition, inkjet recording ink and heterocyclic compound |
02/19/2009 | WO2009022736A1 Heterocyclic compound, ultraviolet ray absorbent, and composition comprising the ultraviolet ray absorbent |
02/19/2009 | US20090048286 Inhibitors of Protein Tyrosine Phosphatase 1B |
02/19/2009 | US20090048273 Premature ovulation preventive agent |
02/19/2009 | US20090048236 New phenylalanine derivatives |
02/18/2009 | EP2024372A2 Thieno [3,2-d] pyrimidine derivative useful as pi3k inhibitor |
02/18/2009 | EP2024371A1 Phenanthrene derivatives as mpges-1 inhibitors |
02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
02/18/2009 | CN101367793A Amino-quinazoline derivative with antineoplastic activity and its salts |
02/17/2009 | US7491742 Benzo(thio)pyrano[3,4-d]imidazol-4-(1H)-onederivatives; antiallergens, antiasthmatics, antitumor, antimetastasis, and antiinflammatory agents; bronchitis, dermatitis, psoriasis; autoimmune diseases; Crohn's disease, multiple sclerosis, AIDS |
02/17/2009 | US7491741 Diaminopropionic acid derivatives |
02/17/2009 | US7491729 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof |
02/12/2009 | WO2009020578A1 Alpha2c adrenoreceptor agonists |
02/12/2009 | WO2009000067A1 Improved processes for the synthesis of olanzapine |
02/12/2009 | WO2008008024A3 Polymorphic forms of spirapril hydrochloride |
02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
02/12/2009 | US20090042929 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
02/12/2009 | US20090042913 Indolylalkylthienopyrimidylamines as modulators of the EP2 receptor |
02/12/2009 | US20090042878 Thienopyrimidylamines as modulators of the ep2 receptor |
02/12/2009 | US20090042877 such as ethyl 6-oxo-7-phenyl-3-(pyridin-3-ylamino)-6,7-dihydrothieno [2,3-b]pyridine-2-carboxylate, potent and selective inhibitors of p38 MAP kinase and are of use in the prophylaxis and treatment of immune or inflammatory disorders |
02/12/2009 | US20090042227 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use |
02/11/2009 | EP1228063B1 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
02/11/2009 | CN101365703A Heteroalkyl linked pyrimidine derivatives |
02/10/2009 | US7488736 serotonin receptor agonist and antagonist; antidepressant, anxoilytic agent, neurodegenerative diseases; neurodegenerative disease, cognition disorders, irritable bowel syndrome, nausea; 6,7-Dihydro-4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamid potassium salt |
02/05/2009 | WO2009016782A1 Blue photochromic compound, photoreversible color-developing composition, and photofunctional material |
02/05/2009 | WO2008091169A3 Process for preparation of substantially pure polymorphic form i of olanzapine |
02/05/2009 | US20090036683 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof |
02/05/2009 | US20090036444 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
02/05/2009 | US20090036443 6-cyclohexyl-5-phenyl-4H-thieno[3,2-b]pyrrole-2-carboxylic acid, used for inhibiting hepatitis C virus polymerase or prevention and treatment of hepatitis C viral infections |
02/05/2009 | US20090035332 Pharmaceutical formulation |
02/04/2009 | EP2020414A1 spiro[piperidine-4,4'-thieno[3,2-c]pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
02/04/2009 | CN101360751A Oxygen linked pyrimidine derivatives |
02/04/2009 | CN101360750A Method of modulating stress-activated protein kinase system |
02/04/2009 | CN101360749A Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations |
02/04/2009 | CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
02/04/2009 | CN100457758C Thienopyrrolizine derivative, its preparing method and pharmaceutical composition containing the same |
02/04/2009 | CN100457733C Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer |
02/04/2009 | CN100457192C Biotin-derivatives and their conjugates with chelating agents |
02/03/2009 | US7485730 Pharmaceutical compounds |
02/03/2009 | US7485427 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
01/29/2009 | WO2009013462A1 Thieno-pyridine derivatives as mek inhibitors |
01/29/2009 | WO2009012679A1 2,2,3a,4-TETRAHYDROTHIOCHROMENE[4,3-C]PYRAZOLE COMPOUNDS, PREPARATION METHOD AND USAGE THEREOF |
01/29/2009 | WO2008152159A3 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators |
01/29/2009 | WO2008104175A3 Novel phosphodiesterase inhibitors |
01/29/2009 | WO2008089453A9 Inhibitors of d-amino acid oxidase |
01/29/2009 | WO2008082839A3 Pim kinase inhibitors as cancer chemotherapeutics |
01/29/2009 | US20090030196 Pim kinase inhibitors as cancer chemotherapeutics |
01/29/2009 | US20090030025 Trans-fused chromenoisoquinolines synthesis and methods for use |
01/29/2009 | US20090030006 sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor; 1,1-anhydro-1-C-[5-(4-ethylphenyl)methyl-2-(hydroxymethyl)phenyl]- beta -D-glucopyranose, for example |
01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
01/29/2009 | US20090029983 Novel heterocyclic compounds having anti-hbv activity |
01/29/2009 | US20090025781 Novel amino group-containing heterocyclic derivatives and sensitizing dyes for photoelectric conversion containing the heterocyclic derivatives |
01/28/2009 | EP2018384A2 Pyrimidine low molecular weight ligands for modulating hormone receptors |
01/28/2009 | CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
01/28/2009 | CN101353352A Hexa-thiophen and derivatives thereof, preparation and use thereof |
01/28/2009 | CN101353351A Novel 2,3,3a,4-tetrahydro thiochromeno [4,3-c] pyrazole antiinflammatory antimycotic compound |
01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
01/28/2009 | CN100455586C Pyrimidothiophene compounds |
01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
01/27/2009 | US7482453 dissolving clopidogrel in ethyl acetate solvent then adding sulfuric acid; good yield and purity of enantiomer |
01/27/2009 | US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
01/27/2009 | US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay |
01/27/2009 | CA2430696C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
01/27/2009 | CA2377226C Benzimidazole compounds and medicaments comprising the same |
01/27/2009 | CA2335115C Fused azepinone cyclin dependent kinase inhibitors |
01/22/2009 | WO2009012430A1 Sulfonamides as trpm8 modulators |
01/22/2009 | WO2009011617A2 ANNELATED AZAHETEROCYCLES COMPRISING PYRIMIDINE FRAGMENT, METHOD FOR THE PRODUCTION THEREOF AND (PI3Ks) KINASE INHIBITORS |
01/22/2009 | WO2009010925A2 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
01/22/2009 | WO2009010824A1 Dihydrochromenopyrazole derivatives as vanilloid receptor ligands |
01/22/2009 | WO2009010791A2 Cyclic ethers |
01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
01/22/2009 | WO2008063202A3 Heterobicyclic thiophene compounds for the treatment of cancer |
01/22/2009 | US20090023741 Aryl/hetarylamides as modulators of the ep2 receptor |
01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
01/22/2009 | CA2693159A1 Sulfonamides as trpm8 modulators |
01/21/2009 | EP2017274A1 Acid-amplifier having acetal group and photoresist composition including the same |
01/21/2009 | EP2016082A2 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
01/21/2009 | EP1549655B1 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
01/21/2009 | CN101348491A Phenyl ethylene end capped tetrathiophen derivative, preparation and use thereof |
01/21/2009 | CN101348490A Preparation of clopidogrel and salt thereof |
01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
01/20/2009 | US7479471 Applying to plants, seeds |
01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
01/15/2009 | WO2009009550A1 Novel compounds as cannabinoid receptor ligands |
01/15/2009 | WO2009007814A1 Inhibitors of carbonic anhydrase |
01/15/2009 | WO2009007422A1 Thienopyrimidylamines as modulators of the ep2 receptor |
01/15/2009 | WO2009007421A1 Indolylalkylthienopyrimidylamines as modulators of the ep2 receptor |
01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
01/15/2009 | US20090018348 Heterocyclic Fused Selenophene Monomers |
01/15/2009 | US20090018329 Novel heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
01/15/2009 | US20090018149 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections |
01/15/2009 | US20090018114 Novel compounds as cannabinoid receptor ligands |
01/15/2009 | US20090017546 Fluorescent isotope tags and their method of use |